Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Drug concentration Live cell count Average live cell count, DMSO control Average live cell count (time = 0) Log10(drug concentration) GR value Relative cell count (treatment versus DMSO) Cell doublings (DMSO control) Experiment name
HCC1806 AZD-6482 3 72
0.1
12053.8 11709.8 1273.3
-1.0
1.020 1.030 3.201
HCC1806 AZD6482 0 3 72
HCC1806 AZD-6482 3 72
0.32
11558.3 11709.8 1273.3
-0.495
0.992 0.987 3.201
HCC1806 AZD6482 0 3 72
HCC1806 AZD-6482 3 72
1.0
11781.3 11709.8 1273.3
0.0
1.000 1.010 3.201
HCC1806 AZD6482 0 3 72
HCC1806 AZD-6482 3 72
3.2
11967.3 11709.8 1273.3
0.505
1.010 1.020 3.201
HCC1806 AZD6482 0 3 72
HCC1806 AZD8055 3 72
0.001
11605.5 11579.3 1273.3
-3.0
1.000 1.000 3.185
HCC1806 AZD8055 0 3 72
HCC1806 AZD8055 3 72
0.0032
11161.5 11579.3 1273.3
-2.49
0.977 0.964 3.185
HCC1806 AZD8055 0 3 72
HCC1806 AZD8055 3 72
0.01
10460.5 11579.3 1273.3
-2.0
0.937 0.903 3.185
HCC1806 AZD8055 0 3 72
HCC1806 AZD8055 3 72
0.032
9150.5 11579.3 1273.3
-1.49
0.858 0.790 3.185
HCC1806 AZD8055 0 3 72
HCC1806 AZD8055 3 72
0.1
7212.5 11579.3 1273.3
-1.0
0.724 0.623 3.185
HCC1806 AZD8055 0 3 72
HCC1806 AZD8055 3 72
0.32
5696.0 11579.3 1273.3
-0.495
0.601 0.492 3.185
HCC1806 AZD8055 0 3 72
HCC1806 AZD8055 3 72
1.0
5727.5 11579.3 1273.3
0.0
0.603 0.495 3.185
HCC1806 AZD8055 0 3 72
HCC1806 AZD8055 3 72
3.2
5607.0 11579.3 1273.3
0.505
0.593 0.484 3.185
HCC1806 AZD8055 0 3 72
HCC1806 Dactolisib 3 72
0.001
11630.8 11670.0 1273.3
-3.0
0.998 0.997 3.196
HCC1806 BEZ235 0 3 72
HCC1806 Dactolisib 3 72
0.0032
10570.3 11670.0 1273.3
-2.49
0.939 0.906 3.196
HCC1806 BEZ235 0 3 72
HCC1806 Dactolisib 3 72
0.01
9243.3 11670.0 1273.3
-2.0
0.859 0.792 3.196
HCC1806 BEZ235 0 3 72
HCC1806 Dactolisib 3 72
0.032
7096.0 11670.0 1273.3
-1.49
0.712 0.608 3.196
HCC1806 BEZ235 0 3 72
HCC1806 Dactolisib 3 72
0.1
6060.8 11670.0 1273.3
-1.0
0.629 0.519 3.196
HCC1806 BEZ235 0 3 72
HCC1806 Dactolisib 3 72
0.32
4335.3 11670.0 1273.3
-0.495
0.467 0.371 3.196
HCC1806 BEZ235 0 3 72
HCC1806 Dactolisib 3 72
1.0
1879.0 11670.0 1273.3
0.0
0.129 0.161 3.196
HCC1806 BEZ235 0 3 72
HCC1806 Dactolisib 3 72
3.2
1409.8 11670.0 1273.3
0.505
0.032 0.121 3.196
HCC1806 BEZ235 0 3 72
HCC1806 Buparlisib 3 72
0.001
11516.0 11660.8 1273.3
-3.0
0.992 0.988 3.195
HCC1806 BKM120 0 3 72
HCC1806 Buparlisib 3 72
0.0032
11494.8 11660.8 1273.3
-2.49
0.991 0.986 3.195
HCC1806 BKM120 0 3 72
HCC1806 Buparlisib 3 72
0.01
11603.0 11660.8 1273.3
-2.0
0.997 0.995 3.195
HCC1806 BKM120 0 3 72
HCC1806 Buparlisib 3 72
0.032
11523.5 11660.8 1273.3
-1.49
0.993 0.988 3.195
HCC1806 BKM120 0 3 72
HCC1806 Buparlisib 3 72
0.1
11343.3 11660.8 1273.3
-1.0
0.983 0.973 3.195
HCC1806 BKM120 0 3 72